Orgenesis appoints Victor Miller as CFO, replacing Elliot Maltz

Orgenesis Inc.

Elliot Maltz resigned as CFO, Treasurer, and Secretary effective Dec 31, 2023; no disagreement with the company.
Victor Miller appointed CFO effective Jan 2, 2024; previously CFO at Hycor Biomedical for 9 years.
Miller receives annual base salary of $335,000 and bonus up to 40% of base salary.
Initial grant of 200,000 stock options vesting quarterly over 2 years; additional options pending shareholder approval.
Employment agreement includes severance: 4-6 months salary and COBRA contributions if terminated without cause.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Elliot Maltz

Chief Financial Officer, Treasurer and Secretary

Orgenesis Inc.

Effective: 2023-12-31
Successor: Victor Miller
Filed: December 29, 2023, 6:59 PM ET

On December 22, 2023, Mr. Elliot Maltz, the Chief Financial Officer, Treasurer and Secretary of Orgenesis Inc. (the "Company"), resigned from all positions he held with the Company to pursue other opportunities.

Appointed

Victor Miller

Chief Financial Officer

Orgenesis Inc.

Effective: 2024-01-02
Filed: December 29, 2023, 6:59 PM ET

On December 28, 2023, the Company appointed Victor Miller as its Chief Financial Officer, effective January 2, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Elliot Maltz resigned as Chief Financial Officer, Treasurer and Secretary at Orgenesis Inc..

Action: resigned
Role: Chief Financial Officer, Treasurer and Secretary

Exact text from the filing

On December 22, 2023, Mr. Elliot Maltz, the Chief Financial Officer, Treasurer and Secretary of Orgenesis Inc. (the "Company"), resigned from all positions he held with the Company to pursue other opportunities.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Victor Miller was appointed as Chief Financial Officer at Orgenesis Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On December 28, 2023, the Company appointed Victor Miller as its Chief Financial Officer, effective January 2, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-23-046575

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.